B-Type Natriuretic Peptides for the Evaluation of Exercise Intolerance

American Journal of Medicine

Volumn 122, Issue 3, 2009, Pages 265-272

  Mueller, Christian ^a   Maeder, Micha T ^a   Christ, Andreas ^a   Reichlin, Tobias ^a   Staub, Daniel ^a   Noveanu, Markus ^a   Breidthardt, Tobias ^a   Potocki, Mihael ^a   Brutsche, Martin H ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Cardiopulmonary exercise testing; Exercise tolerance; Natriuretic peptides; Sensitivity; Specificity

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ACCURACY; ARTICLE; CARDIOPULMONARY EXERCISE TEST; EVALUATION; EXERCISE TOLERANCE; HUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADRENERGIC BETA-ANTAGONISTS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OXYGEN CONSUMPTION; PEPTIDE FRAGMENTS;

EID: 61549096603     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.08.030     Document Type: Article

References (25)

1. American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 167 (2003) 211-277
2. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
3. Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
4. Januzzi J.L., van Kimmenade R., Lainchbury J., et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27 (2006) 330-337
5. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 (2005) 948-954
6. Daniels L.B., and Maisel A.S. Natriuretic peptides. J Am Coll Cardiol 50 (2007) 2357-2368
7. Staub D., Jonas N., Zellweger M.J., et al. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia. Am J Med 118 (2005) 1287
8. Staub D., Nusbaumer C., Zellweger M.J., et al. Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J 151 (2006) 1223-1230
9. Schmid A., Schilter D., Fengels I., et al. Design and validation of an interpretative strategy for cardiopulmonary exercise tests. Respirology 12 (2007) 916-923
10. Guazzi M., Myers J., and Arena R. Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J Am Coll Cardiol 46 (2005) 1883-1890
11. Robbins M., Francis G., Pashkow F.J., et al. Ventilatory and heart rate responses to exercise : better predictors of heart failure mortality than peak oxygen consumption. Circulation 100 (1999) 2411-2417
12. Mueller T., Gegenhuber A., Poelz W., and Haltmayer M. Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay. Clin Chem 50 (2004) 1104-1106
13. Barnes S.C., Collinson P.O., Galasko G., et al. Evaluation of N-terminal pro-B type natriuretic peptide analysis on the Elecsys 1010 and 2010 analysers. Ann Clin Biochem 41 (2004) 459-463
14. Davis M., Espiner E., Richards G., et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 343 (1994) 440-444
15. Mueller C., Breidthardt T., Laule-Kilian K., et al. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 137 (2007) 4-12
16. Martinez-Rumayor A., Richards A.M., Burnett J.C., and Januzzi Jr. J.L. Biology of the natriuretic peptides. Am J Cardiol 101 (2008) 3-8
17. Wermuth J., Staub D., Laule-Kilian K., et al. Neurohormonal activation and left ventricular ejection fraction in patients with suspected myocardial ischemia. Int J Cardiol 120 (2007) 248-253
18. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 (2002) 976-982
19. O'Neill J.O., Bott-Silverman C.E., McRae III A.T., et al. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. Am Heart J 149 (2005) 363-369
20. Forfia P.R., Watkins S.P., Rame J.E., et al. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 45 (2005) 1667-1671
21. Tschope C., Kasner M., Westermann D., et al. Elevated NT-ProBNP levels in patients with increased left ventricular filling pressure during exercise despite preserved systolic function. J Card Fail 11 (2005) S28-S33
22. Marie P.Y., Mertes P.M., Hassan-Sebbag N., et al. Exercise release of cardiac natriuretic peptides is markedly enhanced when patients with coronary artery disease are treated medically by beta-blockers. J Am Coll Cardiol 43 (2004) 353-359
23. de Groote P., Soudan B., Lamblin N., et al. Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?. Am Heart J 148 (2004) 349-355
24. Barletta G., Stefani L., Del Bene R., et al. Effects of exercise on natriuretic peptides and cardiac function in man. Int J Cardiol 65 (1998) 217-225
25. Nicholson S., Richards M., Espiner E., et al. Atrial and brain natriuretic peptide response to exercise in patients with ischaemic heart disease. Clin Exp Pharmacol Physiol 20 (1993) 535-540